Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Journal of Cellular Physiology|February 22, 2002
EGFR-independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analogSiddhartha Kar, Takahito Adachi, Brian I CarrJournal of Cellular Physiology|October 18, 2002
K vitamins, PTP antagonism, and cell growth arrestBrian I Carr, Ziqiu Wang, Siddhartha KarCancer Chemotherapy and Pharmacology|February 5, 2008
2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosisSiddhartha Kar, Meifang Wang, Brian I CarrMolecular and Cellular Biochemistry|May 23, 2007
alpha-Thrombin inhibits DNA synthesis in rat hepatocytes but not in hepatoma cells by receptor activation and proteolysisSiddhartha Kar, Meifang Wang, Brian I CarrCureus|April 27, 2026
Assessment of Retinal Nerve Fiber Layer Changes in Patients With Chronic Kidney Disease: A Cross-Sectional StudySubhangi Sahu, Saswati Sen, Matuli Das, et al.Journal of Cellular Physiology|July 13, 2002
Transient and sustained ERK phosphorylation and nuclear translocation in growth controlTakahito Adachi, Siddhartha Kar, Meifang Wang, et al.Cell Biology International|May 11, 2007
Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrixBrian I Carr, Siddhartha Kar, Meifang Wang, et al.Biochemical Pharmacology|August 26, 2006
Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPKSiddhartha Kar, Meifang Wang, Seung Wook Ham, et al.Carcinogenesis|March 29, 2003
Antitumor and anticarcinogenic actions of Cpd 5: a new class of protein phosphatase inhibitorSiddhartha Kar, Meifang Wang, Craig S Wilcox, et al.Cancer Biology & Therapy|September 14, 2006
H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERKSiddhartha Kar, Meifang Wang, Seung Wook Ham, et al.Pageof 9